A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 strange trades.
If we consider the specifics of each trade, it is accurate to state that 29% of the investors opened trades with bullish expectations and 70% with bearish.
From the overall spotted trades, 10 are puts, for a total amount of $517,940 and 7, calls, for a total amount of $260,011.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $250.0 for Moderna over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1084.64 with a total volume of 1,962.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $100.0 to $250.0 over the last 30 days.
Moderna Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 06/16/23 | $240.00 | $156.8K | 383 | 4 |
| MRNA | PUT | SWEEP | BEARISH | 03/17/23 | $100.00 | $96.8K | 386 | 545 |
| MRNA | PUT | TRADE | BEARISH | 01/20/23 | $250.00 | $51.9K | 560 | 0 |
| MRNA | CALL | TRADE | BULLISH | 01/20/23 | $170.00 | $45.7K | 1.3K | 50 |
| MRNA | CALL | SWEEP | BEARISH | 11/18/22 | $150.00 | $44.5K | 2.0K | 105 |
Where Is Moderna Standing Right Now?
- With a volume of 1,761,377, the price of MRNA is up 1.51% at $144.14.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 7 days.
What The Experts Say On Moderna:
- JP Morgan has decided to maintain their Neutral rating on Moderna, which currently sits at a price target of $122.
- SVB Leerink upgraded its action to Market Perform with a price target of $101
- Goldman Sachs has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $296.
- Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently sits at a price target of $175.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
